4 employees
Imuno develops a structure-based discovery engine to identify cancer-specific epitopes.
2020
$338K
from 1 investors over 1 rounds
Imuno Therapeutics raised $338K on November 19, 2021
Investors: Libertatis Ergo Holding B.V.